Medicine. A portfolio model of drug development for tuberculosis.
Publication
, Journal Article
Glickman, SW; Rasiel, EB; Hamilton, CD; Kubataev, A; Schulman, KA
Published in: Science
March 3, 2006
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Science
DOI
EISSN
1095-9203
Publication Date
March 3, 2006
Volume
311
Issue
5765
Start / End Page
1246 / 1247
Location
United States
Related Subject Headings
- United States
- Tuberculosis
- Time Factors
- Public Sector
- Probability
- Private Sector
- National Institutes of Health (U.S.)
- Monte Carlo Method
- Humans
- General Science & Technology
Citation
APA
Chicago
ICMJE
MLA
NLM
Glickman, S. W., Rasiel, E. B., Hamilton, C. D., Kubataev, A., & Schulman, K. A. (2006). Medicine. A portfolio model of drug development for tuberculosis. Science, 311(5765), 1246–1247. https://doi.org/10.1126/science.1119299
Glickman, Seth W., Emma B. Rasiel, Carol Dukes Hamilton, Arsen Kubataev, and Kevin A. Schulman. “Medicine. A portfolio model of drug development for tuberculosis.” Science 311, no. 5765 (March 3, 2006): 1246–47. https://doi.org/10.1126/science.1119299.
Glickman SW, Rasiel EB, Hamilton CD, Kubataev A, Schulman KA. Medicine. A portfolio model of drug development for tuberculosis. Science. 2006 Mar 3;311(5765):1246–7.
Glickman, Seth W., et al. “Medicine. A portfolio model of drug development for tuberculosis.” Science, vol. 311, no. 5765, Mar. 2006, pp. 1246–47. Pubmed, doi:10.1126/science.1119299.
Glickman SW, Rasiel EB, Hamilton CD, Kubataev A, Schulman KA. Medicine. A portfolio model of drug development for tuberculosis. Science. 2006 Mar 3;311(5765):1246–1247.
Published In
Science
DOI
EISSN
1095-9203
Publication Date
March 3, 2006
Volume
311
Issue
5765
Start / End Page
1246 / 1247
Location
United States
Related Subject Headings
- United States
- Tuberculosis
- Time Factors
- Public Sector
- Probability
- Private Sector
- National Institutes of Health (U.S.)
- Monte Carlo Method
- Humans
- General Science & Technology